ArticleMolecular therapy. Oncology2025

Boosting anti-tumor immunity with TILT-517 oncolytic adenovirus and checkpoint blockade in renal cell carcinoma.

Victor Arias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.